POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Canada secures vaccine supply beyond 2021

Christian Fernsby |
Anita Anand, Minister of Public Services and Procurement, announced that Canada has secured COVID-19 vaccines from Pfizer for 2022 and 2023, with options to extend into 2024.

Article continues below




The agreement guarantees access to 65 million doses of Pfizer-BioNTech’s COVID-19 vaccine, with access to up to 120 million more if all options are exercised.

In addition to providing booster vaccine doses, the agreement provides flexibility to procure future COVID-19 vaccine formulations from Pfizer, such as those to protect against variants of concern and vaccines developed for children.

Importantly, these doses are in addition to the 48 million doses of Pfizer-BioNTech’s COVID-19 vaccine arriving before the end of September 2021 as part of Canada’s existing agreement.

Canada’s existing bilateral agreement with Pfizer is for up to 76 million doses of its mRNA vaccine BNT162, 48 million of which will be delivered before the end of September 2021.

As part of the new agreement with Pfizer:

• Canada has secured access to a guaranteed 35 million doses of Pfizer-BioNTech’s COVID-19 vaccines for 2022, with options for up to 30 million more.

• For 2023, Canada has secured access to a guaranteed 30 million doses, with options for 30 million more.

• 2024 is an option year. If this option is exercised, Canada will have access to another 30 million doses, with options for an additional 30 million.


What to read next

New vaccine to provide 2-year protection
Moderna begins testing next-generation coronavirus vaccine
Finnish researchers introduce nasal COVID vaccine